Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
Prevision PRO icon

3.0.0 by Advances & More SARL


Feb 17, 2018

About Prevision PRO

Owned & Powered by Advances&More S.A.R.L

This unique platform is made to update doctors in seconds on the most latest medical news, in each medical specialty from TOP international medical journals & societies such as European, American, Canadian, Asian medical journals, besides, the FDA, WHO, EMEA, European Medicines Agency, European Commission Agency, Recent Drug Approvals, Advisory Committee updates with more than 4000 medical source engines from all specialties keeping doctors updated about the latest developments, each in his therapeutic field.

This platform is also a place for doctors to broadcast their news, activities, and case studies, along with the sponsor news and congresses at the same time.

Voting, Media are also present for doctors to share feedback, opinions and see the videos done.

Disclaimer: the links and websites to the third party present in the platform are provided for references, we are not responsible for the content of the third party websites and or links.

What's New in the Latest Version 3.0.0

Last updated on Feb 17, 2018

Update session time

Translation Loading...

Additional APP Information

Latest Version

Request Prevision PRO Update 3.0.0

Uploaded by

Medồ Majeď

Requires Android

Android 4.1+

Available on

Get Prevision PRO on Google Play

Show More

Prevision PRO Screenshots

Comment Loading...
Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.